发布求助
文献互助 智能选刊 最新文献

INDIAN DRUGS最新文献

筛选
英文 中文
FORCED DEGRADATION STUDIES OF VINCAMINE BY HPTLC hptlc 对长春胺的强制降解研究
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.14129
Christina V. John, Aruna P. Jadhav
{"title":"FORCED DEGRADATION STUDIES OF VINCAMINE BY HPTLC","authors":"Christina V. John, Aruna P. Jadhav","doi":"10.53879/id.60.11.14129","DOIUrl":"https://doi.org/10.53879/id.60.11.14129","url":null,"abstract":"Vincamine is an alkaloid with vasodilator properties. Vinpocetine, a semi-synthetic vincamine derivative alkaloid, is used to treat cerebrovascular diseases like stroke and dementia. Being an important molecule, the current research work examines the forced degradation studies of vincamine using planar chromatography, HPTLC using stability studies parameters such as degradation by acid and base hydrolysis, oxidative stress degradation, hydrolytic induced degradation, photolytic degradation and dry heat degradation. The compound was found to be stable to oxidative stress, but significant degradation occurred under acid hydrolysis, base hydrolysis, water hydrolysis, and to a lesser extent, under thermal stress and photolytic stress. The percentage recovery of vincamine was found to be lower in acidinduced degradation (31.8 %), and base-induced degradation (8.2 %) than in UV-induced degradation (94.9 %) and dry heat-induced degradation (93.1 %). In pharmaceutical research and development, forced degradation experiments are essential for predicting long-term stability.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139216876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
STABILITY INDICATING HPTLC METHOD DEVELOPMENT AND VALIDATION FOR CERITINIB IN BULK AND FORMULATION 色瑞替尼原药和制剂的稳定性指示 Hptlc 方法的开发与验证
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.13584
S. Gandhi, Shivani R. Sawarkar, M. Damle
{"title":"STABILITY INDICATING HPTLC METHOD DEVELOPMENT AND VALIDATION FOR CERITINIB IN BULK AND FORMULATION","authors":"S. Gandhi, Shivani R. Sawarkar, M. Damle","doi":"10.53879/id.60.11.13584","DOIUrl":"https://doi.org/10.53879/id.60.11.13584","url":null,"abstract":"Ceritinib is an anti-cancer of drug used in treatment of non-small cell lung cancer. A high-performance thin layer chromatography (HPTLC) method has been developed for ceritinib, which is stability indicating and simple, precise, and discriminating. The stationary phase used was aluminum-backed silica gel60 F254 plates with chloroform: methanol: glacial acetic acid as the mobile phase in the ratio of 8.5:1.5:0.5 (V/V/V). The retention factor was found to be 0.34 ± 0.02. The densitometric scanning was performed at 277 nm. The linear range for analysis was 100–600 ng band-1, which gave good linear relationship with regression coefficient of 0.998. Method accuracy was proved by the recovery studies. The detection limit and quantification limit were 7.38 and 10.03 ng band-1, respectively. Stress degradation studies like hydrolysis under different pH conditions, photolytic, thermal, and oxidative degradation were carried out as per ICH Q1A (R2) and Q1B guidelines. The method established was found to be robust, and thus it can be used as a stability-indicating method.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139221179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A NOVEL STABILITY INDICATING UV SPECTROSCOPIC METHOD FOR SIMULTANEOUS ESTIMATION OF AZELNIDIPINE AND CHLORTHALIDONE IN ITS PURE AND PHARMACEUTICAL DOSAGE FORM 一种新型稳定性指示紫外光谱法同时测定阿折地平和氯塞酮的纯品及药物剂型
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.13731
Swapna A. Surendran, Haribabu Y., S. V. Kutty, Sreelekha P. Pavithran, Niranjana C. Muralidharan
{"title":"A NOVEL STABILITY INDICATING UV SPECTROSCOPIC METHOD FOR SIMULTANEOUS ESTIMATION OF AZELNIDIPINE AND CHLORTHALIDONE IN ITS PURE AND PHARMACEUTICAL DOSAGE FORM","authors":"Swapna A. Surendran, Haribabu Y., S. V. Kutty, Sreelekha P. Pavithran, Niranjana C. Muralidharan","doi":"10.53879/id.60.11.13731","DOIUrl":"https://doi.org/10.53879/id.60.11.13731","url":null,"abstract":"An accurate, precise and simple stability indicating ultraviolet spectroscopic technique was developed to quantify azelnidipine and chlorthalidone, simultaneously was bulk and in combination by absorbance correction method. Ethanol (99.9 %) is used as the solvent in the method. The detection wavelength was found to be 275 nm for chlorthalidone, and 345 nm for azelnidipine. The methodology was validated concerning sensitivity, linearity, reproducibility, accuracy, ruggedness and robustness. Beer-Lamberts law was obeyed in the concentration from 3.2–80 µg mL-1 in case of azelnidipine and 5-125 µg mL-1 in case of chlorthalidone. Detection limits were obtained as 1.74 µg mL-1 for azelnidipine and 2.376 µg mL-1 for chlorthalidone. For azelnidipine, quantification limit was 5.272 µg mL-1, while for chlorthalidone it was 7.2 µg mL-1. Accelerated stability studies were carried out. Azelnidipine and chlorthalidone showed different degradation characteristics under acid, alkali, humidity, heats, and oxidized environment.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"46 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139225274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CHALLENGES AND OPPORTUNITIES WITH DRUG REPURPOSING: AN EMERGING TECHNIQUE IN DRUGS DISCOVERY 药物再利用的挑战与机遇：药物再利用的挑战与机遇：药物发现中的一种新兴技术
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.13058
Sanyogita Harale, Pooja Hupare, P. Ghatage, Vijaya Govande, Omkar Gurav, Sandip Bandgar, Sachin Patil, Dinanath Gaikwad
{"title":"CHALLENGES AND OPPORTUNITIES WITH DRUG REPURPOSING: AN EMERGING TECHNIQUE IN DRUGS DISCOVERY","authors":"Sanyogita Harale, Pooja Hupare, P. Ghatage, Vijaya Govande, Omkar Gurav, Sandip Bandgar, Sachin Patil, Dinanath Gaikwad","doi":"10.53879/id.60.11.13058","DOIUrl":"https://doi.org/10.53879/id.60.11.13058","url":null,"abstract":"The term “drug repurposing” refers to the practice of identifying unmet medical needs and developing innovative solutions using already available drugs. It’s a useful strategy for identifying or developing new medicinal molecules with untapped therapeutic potential. Some of the computational drugs repurposing methods currently in use have been employed in the fight against the 2019 coronavirus illness (COVID-19) pandemic. Many currently used medications are being repurposed, thanks to advances in computational approaches and a fundamental understanding of viral etiology and pharmacological pharmacodynamics. The objective of this work is to highlight the utilization of repurposed medicines for COVID-19, bacterial infections and cancer therapy. The drug repurposing method is fast-growing in both business and academia, since it focuses on the initial knowledge and investment that brought the product to market in the first place. Recently, medication repositioning has been included in the drug R&D plans of several pharmaceutical companies, aiming to create new therapies in response to the identification of novel biological targets. In addition to being highly efficient, the drug repurposing method also saves money and the pharmacological profiles are generally known.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"173 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139220522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OMEGA-3 – ONLY VIRTUALLY BENEFICIAL FOR THE VEGANS & FANATIC VEGETARIANS! 欧米伽-3--实际上只对素食主义者和狂热的素食者有益！
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.p0005
{"title":"OMEGA-3 – ONLY VIRTUALLY BENEFICIAL FOR THE VEGANS & FANATIC VEGETARIANS!","authors":"","doi":"10.53879/id.60.11.p0005","DOIUrl":"https://doi.org/10.53879/id.60.11.p0005","url":null,"abstract":"Dear Reader, Dinner table conversations revolve around food, travel, politics and now, increasingly, health and nutrition – post the COVID-19 surge. Amongst the conditions commonly discussed, products for immunity, diabetes and heart disease take precedence. Besides immune builders, omega-3 (also referred to as n-3) has become the ‘talk of the town’ since it can benefit both the heart and also diabetes from which nearly 10% of urban Indians suffer.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139221353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EXPLORATION OF MECHANISM OF HYGROPHILA AURICULATA TO TREAT CARBOPLATIN INDUCED TOXICITIES BUILT ON NETWORK PHARMACOLOGY 以网络药理学为基础，探索百日草治疗卡铂所致毒性的机制
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.13955
Arpita Chakraborty, R. S. Parveen, Sangita Kamath, Veena Nayak, Suchetha P. Kumar, V. Belle
{"title":"EXPLORATION OF MECHANISM OF HYGROPHILA AURICULATA TO TREAT CARBOPLATIN INDUCED TOXICITIES BUILT ON NETWORK PHARMACOLOGY","authors":"Arpita Chakraborty, R. S. Parveen, Sangita Kamath, Veena Nayak, Suchetha P. Kumar, V. Belle","doi":"10.53879/id.60.11.13955","DOIUrl":"https://doi.org/10.53879/id.60.11.13955","url":null,"abstract":"Hygrophila auriculata is a traditional herb used for several ailments, with an unclear mechanism of action. The present study aimed to detect its efficacy on nephrotoxicity and hepatotoxicity in Wistar rats followed by network pharmacology analysis to explain its mechanism of action. 24 rats were divided into 4 groups (n=6). After baseline blood investigations, group 1 was treated with normal saline on 13th day, groups 2-4 with carboplatin, groups 3, 4 with different strengths of H. auriculata (day 15 to 30). The active components along with targets of H. auriculata were screened and overall network was created using Cytoscape software. We made preliminary predictions about the major active components, targets along with signalling pathways of H. auriculata to treat carboplatin induced hepatotoxicity and nephrotoxicity, which could pave way for clinical application of H. auriculata against carboplatin induced toxicities.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139225224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DEVELOPMENT OF ERLOTINIB ENCAPSULATED SELF-ASSEMBLED MIXED MICELLES: OPTIMIZATION AND IN VITRO EVALUATION 开发厄洛替尼包裹的自组装混合胶束：优化和体外评估
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.13223
Shruti Patel, Asha Patel
{"title":"DEVELOPMENT OF ERLOTINIB ENCAPSULATED SELF-ASSEMBLED MIXED MICELLES: OPTIMIZATION AND IN VITRO EVALUATION","authors":"Shruti Patel, Asha Patel","doi":"10.53879/id.60.11.13223","DOIUrl":"https://doi.org/10.53879/id.60.11.13223","url":null,"abstract":"For the treatment of lung cancer, erlotinib is used as primary treatment. Erlotinib is an epidermal growth factor receptor inhibitor, however it is deposited in normal cells also and clinicians do not prefer it. This constraint opens the way for development of targeted therapy. Mixed micelles via self-assembly have the functionality to improve the delivery of hydrophobic drugs, and improve the pharmacokinetics of the loaded drug. Pluronic® F127 and tocopheryl polyethylene glycol succinate were used to prepare micelles. BoxBehnken design was applied to optimize formulation. With optimum ratio, micelles were characterized, and pharmacokinetic parameters were predicted. Design batches F1 to F15, showed the range of 42-133 nm size and 55-82 % of entrapment. Critical micelles concentration was found to be 3 × 10-5 M. Drug release of optimized mixed micelles was found 84.91± 1.58 % in 72 h. In a nutshell, self-assembled mixed micelles would be a suitable delivery platform for targeting anticancer agents.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"25 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139217018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FORMULATION OF VITEX NEGUNDO ETHOSOMAL LOADED TOPICAL HERBAL GEL AND ITS EVALUATION FOR ARTHRITIS TREATMENT 蔓荆子乙素负载外用草药凝胶的配方及其对关节炎治疗的评估
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.13963
Pratiksha S. Dhembare, Priyanka G. Kusarkar, Archana S. Murgunde
{"title":"FORMULATION OF VITEX NEGUNDO ETHOSOMAL LOADED TOPICAL HERBAL GEL AND ITS EVALUATION FOR ARTHRITIS TREATMENT","authors":"Pratiksha S. Dhembare, Priyanka G. Kusarkar, Archana S. Murgunde","doi":"10.53879/id.60.11.13963","DOIUrl":"https://doi.org/10.53879/id.60.11.13963","url":null,"abstract":"The current research aims to develop and test a system of vesicular drug carriers for topical drug administration of Vitex negundo Linn. to provide sustained drug delivery. The ethosomes of V. negundo Linn. were produced using thin-film hydration, and their in vitro drug release profiles, size, drug content, and other characteristics were examined. To attain the desired results, for drug release and entrapment effectiveness, the composition of lecithin and ethanol was changed to form ethosomes. The ethosomal size of the vesicle of the optimized formulation batch was measured to be the units 13.47 nm with -3.97 mV as zeta potential. The percent drug release of ethosomal gel was 83.24 %, and the percent entrapment efficiency was 89.40 %. The formation of spherically shaped vesicles was confirmed by optical and scanning electron microscopy observations. It was observed that as the ethanol concentration increased, the formulation’s in vitro profile for drug release increase, and lipid concentration decreases.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139222792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COMPARATIVE ANALYSIS OF THE BIOLOGICAL PROPERTIES OF ETHANOL EXTRACTS OF THE GENUS MONARDA REPRESENTATIVES ON THE EXAMPLE OF DROSOPHILA MELANOGASTER 以黑腹果蝇为例比较分析猴面包树属代表植物乙醇提取物的生物特性
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.13711
O. Antosyuk, E. Bolotnik, Irina A. Sakova
{"title":"COMPARATIVE ANALYSIS OF THE BIOLOGICAL PROPERTIES OF ETHANOL EXTRACTS OF THE GENUS MONARDA REPRESENTATIVES ON THE EXAMPLE OF DROSOPHILA MELANOGASTER","authors":"O. Antosyuk, E. Bolotnik, Irina A. Sakova","doi":"10.53879/id.60.11.13711","DOIUrl":"https://doi.org/10.53879/id.60.11.13711","url":null,"abstract":"Determination of toxic, genotoxic and cytotoxic effects of Drosophila melanogaster for Monarda fistulosa var. menthifolia, M. fistulosa, M. didyma and M. media was carried out. The Oregon-R line was used to test for toxic manifestations in a number of indicators: fecundity, early and late embryonic mortality of offspring and total lethality of individuals (LC50). The genotoxic effect was recorded using SMART. The change in the wing shape and regulated cell death was determined. The lethality of individuals grown on a nutrient medium with the addition of an extract of M. fistulosa var. menthifolia, as well as F1 offspring at the embryonic stage of development was studied. Genotoxicity was not registered for any of the tested extracts. The M. didyma extract is characterized by cytotoxic properties. An effect on viability was found for extracts of M. media and M. fistulosa var. menthifolia. Cytotoxic effect was observed when exposed to M. didyma extract.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139224756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ANALYTICAL UV SPECTROSCOPY METHOD DEVELOPMENT AND VALIDATION STUDIES FOR SIMULTANEOUS ESTIMATION OF METFORMIN HCL AND QUERCETIN 同时测定二甲双胍盐酸盐和槲皮素的紫外光谱分析方法开发与验证研究
INDIAN DRUGS Pub Date : 2023-11-28 DOI: 10.53879/id.60.11.14088
Rushikesh Mali, Tabassum Khan
{"title":"ANALYTICAL UV SPECTROSCOPY METHOD DEVELOPMENT AND VALIDATION STUDIES FOR SIMULTANEOUS ESTIMATION OF METFORMIN HCL AND QUERCETIN","authors":"Rushikesh Mali, Tabassum Khan","doi":"10.53879/id.60.11.14088","DOIUrl":"https://doi.org/10.53879/id.60.11.14088","url":null,"abstract":"In the current investigation, we have designed and assessed a simple and swift analytical approach employing UV spectroscopy for the simultaneous quantification of the analytes metformin and quercetin with excellent precision and accuracy. The wavelengths of interest are the wavelengths at which both the drugs show maximum absorbance: 233 nm for metformin and 256 nm for quercetin. Linearity study, conducted in methanol and phosphate buffer, yielded a correlation coefficient (r2 ) of 0.99. The validation study for the developed method was conducted in accordance with ICH Q2 R1 guidelines. The percent recovery was 95% to 105%, and the percent relative standard deviation was <2, demonstrating the accuracy and precision of this method. This method can be applied to analysis of the two compounds in fixed dose formulations using simple UV spectroscopy.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":"46 6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139217893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信